Multiple myeloma (MM) is a hematologic cancer characterized by clonal proliferation of plasma cells in the bone marrow (BM). The progression, from the early stages of the disease as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) to MM and occasionally extramedullary disease, is drastically affected by the tumor microenvironment (TME). Soluble factors and direct cell–cell interactions regulate MM plasma cell trafficking and homing to the BM niche. Mesenchymal stromal cells, osteoclasts, osteoblasts, myeloid and lymphoid cells present in the BM create a unique milieu that favors MM plasma cell immune evasion and promotes disease progression. Moreover, TME is implicated in malignant cell protect...
Multiple myeloma (MM) is a cancer of plasma cells in the bone marrow (BM) and represents the second ...
Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasm...
Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasm...
Multiple myeloma (MM) is a hematological malignancy of plasma cells that proliferate and accumulate ...
: Multiple myeloma (MM) is an incurable hematologic malignancy characterized by a multistep evolutio...
Substantial advances have been made in understanding the biology of multiple myeloma (MM) through th...
Myeloid derived suppressors cells (MDSC) play major roles in regulating immune homeostasis and immun...
© 2021 by the authors.Multiple myeloma (MM) is a hematological malignancy of plasma cells that proli...
The growth, survival and proliferation of cancer cells are guaranteed by a crosstalk between cancer ...
The growth, survival and proliferation of cancer cells are guaranteed by a crosstalk between cancer ...
Multiple Myeloma (MM) is a systemic hematologic disease due to uncontrolled proliferation of monoclo...
Much has been learnt in the past few years about how the microenvironment influences bone destructio...
Multiple myeloma (MM) drug resistance (DR) is a multistep transformation process based on a powerful...
Multiple Myeloma (MM) is a cancer of plasma cells resulting from the abnormal proliferation of malig...
Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasm...
Multiple myeloma (MM) is a cancer of plasma cells in the bone marrow (BM) and represents the second ...
Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasm...
Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasm...
Multiple myeloma (MM) is a hematological malignancy of plasma cells that proliferate and accumulate ...
: Multiple myeloma (MM) is an incurable hematologic malignancy characterized by a multistep evolutio...
Substantial advances have been made in understanding the biology of multiple myeloma (MM) through th...
Myeloid derived suppressors cells (MDSC) play major roles in regulating immune homeostasis and immun...
© 2021 by the authors.Multiple myeloma (MM) is a hematological malignancy of plasma cells that proli...
The growth, survival and proliferation of cancer cells are guaranteed by a crosstalk between cancer ...
The growth, survival and proliferation of cancer cells are guaranteed by a crosstalk between cancer ...
Multiple Myeloma (MM) is a systemic hematologic disease due to uncontrolled proliferation of monoclo...
Much has been learnt in the past few years about how the microenvironment influences bone destructio...
Multiple myeloma (MM) drug resistance (DR) is a multistep transformation process based on a powerful...
Multiple Myeloma (MM) is a cancer of plasma cells resulting from the abnormal proliferation of malig...
Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasm...
Multiple myeloma (MM) is a cancer of plasma cells in the bone marrow (BM) and represents the second ...
Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasm...
Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasm...